National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

NCPE review of Adenuric (Febuxostat®) a xanthine oxidase inhibitor for the treatment of gout.

Rapid Review

Commenced Completed Outcome
08/12/2009 Full Pharmacoeconomic Evaluation not Recommended